Liver Disorders Clinical Trials

A listing of Liver Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 48 clinical trials
Impact of SFV of Proximal Colon on ADR

To evaluate the impact of second forward view examination of the proximal colon on adenoma detection rate Inclusion criteriaPatients 18 years of age undergoing screening, follow-up monitoring, and diagnostic colonoscopy Exclusion criteriaCecal intubation failed. Have a history of colorectal surgery. Insufficient bowel preparation, Boston Bowel Preparation Score (BBPS) <6 points. …

  • 0 views
  • 23 Jul, 2021
  • 1 location
Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus

Systemic lupus erythematosus is a chronic and multisystemic autoimmune disorder which predominantly affecting women. The most common cause of death in lupus patients affected by disease for more than 5 years is cardiovascular disease due to presence of some factors as oxidative stress, pro-inflammatory cytokines , dyslipidemia, diabetes, and hypertension.

diabetes
cardiovascular disease
  • 0 views
  • 31 Jul, 2021
  • 1 location
Zhizhu Kuanzhong Capsule for Patients With Functional Dyspepsia-Postprandial Distress Syndrome

A 13 weeks randomized, double-blind and placebo parallel-controlled trial will be conducted to evaluate the clinical efficacy and safety of Zhizhu Kuanzhong Capsule in the treatment of functional dyspepsia-postprandial distress syndrome.

  • 3 views
  • 24 Jul, 2021
  • 1 location
Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

This is a randomized, sham controlled, dose finding study of the EmitBio RD-X19 device in individuals with symptomatic COVID-19 in the outpatient setting.

  • 0 views
  • 27 Jul, 2021
  • 2 locations
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis

We aim to assess the effect of Ofatumumab on microglial activation using [F-18]PBR06 PET in MS patients in relation to changes in serum markers, MRI abnormalities and clinical impairment longitudinally over 9 months. Specific Aims: Specific Aim 1: To determine the effect of Ofatumumab on microglial activation in MS over …

  • 0 views
  • 02 Aug, 2021
  • 1 location
Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

works in a way that makes the liver produce less of a substance called 'PCSK9'. PCSK9 reduces the ability of the liver to remove LDL-cholesterol from the blood. By lowering the production of PCSK9

  • 0 views
  • 04 Aug, 2021
  • 1 location
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

This is a prospective, multicenter, randomized, parallel controlled, open-label study. The primary purpose of this study is to evaluate the efficacy of Huaier Granule on postoperative adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma. The Secondary purposes are to evaluate the safety of long-term use of Huaier granules as …

carcinoma
ductal carcinoma
tumor cells
metastasis
  • 0 views
  • 29 Jul, 2021
  • 1 location
Interaction Between Cannabidiol Meal Ingestion and Liver Function

different formulations of CBD on markers of liver function.

  • 0 views
  • 31 Jul, 2021
  • 1 location
Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping

application of laser on acupoints (for month, except Fridays) in fatty liver patients. This trial will compare the two procedure effects on cardio-metabolic risk factors in fatty liver.

  • 0 views
  • 02 Aug, 2021
  • 1 location
ECT204 T-Cell Therapy in Adults With Advanced HCC

This will be an open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety of ECT204 T-cell therapy and determine the RP2D in adult subjects ( 18 years of age) who have GPC3-positive HCC and have failed or not tolerated at least two (2) different anti-HCC systemic agents.

measurable disease
tumor cells
immunohistochemistry
  • 0 views
  • 01 Aug, 2021
  • 2 locations